The Relationship Between HIV Pre-exposure Prophylaxis Stigma and Treatment Adherence Among Current HIV Pre-exposure Prophylaxis Users in the Southeastern US

被引:4
作者
Van Gerwen, Olivia T. [1 ]
Yigit, Ibrahim [2 ]
Crockett, Kaylee B. [3 ]
Turan, Bulent [4 ,5 ]
机构
[1] Univ Alabama Birmingham, Div Infect Dis, 703 19th St South,ZRB 218A, Birmingham, AL 35233 USA
[2] TED Univ, Fac Arts & Sci, Dept Psychol, Ankara, Turkey
[3] Univ Alabama Birmingham, Dept Family & Community Med, Birmingham, AL USA
[4] Koc Univ, Coll Social Sci & Humanities, Dept Psychol, Istanbul, Turkey
[5] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA
基金
美国国家卫生研究院;
关键词
HIV pre-exposure prophylaxis; Adherence; Stigma; PrEP; TENOFOVIR DISOPROXIL FUMARATE; INTERNALIZED STIGMA; PREVENTION; MECHANISMS; INFECTION; EFFICACY; PEOPLE; SCALE; RISK; PREP;
D O I
10.1007/s10461-022-03883-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Despite efficacy in HIV prevention, Pre-exposure Prophylaxis (PrEP) is underutilized in the US, especially among populations at highest risk. PrEP-related stigma may play a role. We developed measures of PrEP-related stigma dimensions and PrEP adherence. We administered them to current PrEP users. We hypothesized that PrEP-related stigma would negatively impact PrEP adherence. Questionnaire measures were developed using data from previous qualitative work and existing validated HIV-related stigma measures. The resultant survey was administered to current PrEP users from two Birmingham, Alabama PrEP clinics. Plasma tenofovir disoproxil fumarate levels were collected to measure PrEP adherence. Exploratory factor analyses were performed to determine the factor structure of each PrEP-related stigma dimension (internalized, perceived, experienced, anticipated, disclosure concerns). Separate binary logistic (or linear) regressions were performed to assess associations between PrEP-related stigma dimensions and adherence (treatment adherence self-efficacy, self-reported adherence, and plasma tenofovir levels), adjusting for education, race, and time on PrEP. In 2018, 100 participants completed the survey, with 91 identifying as male and 66 as white. Only internalized stigma was associated with lower self-reported PrEP adherence. Exploratory mediation analyses suggested that the association between all stigma dimensions and self-reported PrEP adherence is mediated by PrEP adherence self-efficacy. No associations were found between any PrEP-related stigma measures and plasma tenofovir levels. Internalized PrEP stigma may reduce PrEP adherence, possibly by reducing PrEP adherence self-efficacy among experienced PrEP users. Further investigation of how stigma dimensions affect PrEP adherence in populations at risk for HIV may shed light on drivers of PrEP underutilization.
引用
收藏
页码:1478 / 1485
页数:8
相关论文
共 50 条
  • [31] Adherence to HIV Pre-Exposure Prophylaxis Testing Guidelines in the United States
    McCormick, Carter D.
    Sullivan, Patrick S.
    Qato, Dima M.
    Crawford, Stephanie Y.
    Schumock, Glen T.
    Lee, Todd A.
    AIDS PATIENT CARE AND STDS, 2023, 37 (07) : 337 - 350
  • [32] A Review of HIV Pre-exposure Prophylaxis Streamlining Strategies
    Siegler, Aaron J.
    Steehler, Kevin
    Sales, Jessica M.
    Krakower, Douglas S.
    CURRENT HIV/AIDS REPORTS, 2020, 17 (06) : 643 - 653
  • [33] Top Questions in ID: Pre-exposure Prophylaxis for HIV
    Krakower, Douglas S.
    Cohen, Stephanie E.
    Mayer, Kenneth H.
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (04):
  • [34] A Review of HIV Pre-Exposure Prophylaxis: The Female Perspective
    Bailey, Jennifer L.
    Molino, Suzanne T.
    Vega, Ana D.
    Badowski, Melissa
    INFECTIOUS DISEASES AND THERAPY, 2017, 6 (03) : 363 - 382
  • [35] An Overview of Antiretroviral Pre-Exposure Prophylaxis of HIV Infection
    McGowan, Ian
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2014, 71 (06) : 624 - 630
  • [36] Pre-exposure prophylaxis for HIV prevention in East and Southern Africa
    van der Wal, Ran
    Loutfi, David
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2017, 108 (5-6): : E643 - E645
  • [37] Pre-exposure of Prophylaxis to Prevent HIV Infection - current Data and Recommendations
    Kuemmerle, T.
    Foewtkenheuer, G.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (44) : 2285 - 2288
  • [38] Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis
    Tan, Darrell H. S.
    Hull, Mark W.
    Yoong, Deborah
    Tremblay, Cecile
    O'Byrne, Patrick
    Thomas, Rejean
    Kille, Julie
    Baril, Jean-Guy
    Cox, Joseph
    Giguere, Pierre
    Harris, Marianne
    Hughes, Christine
    MacPherson, Paul
    O'Donnell, Shannon
    Reimer, Joss
    Singh, Ameeta
    Barrett, Lisa
    Bogoch, Isaac
    Jollimore, Jody
    Lambert, Gilles
    Lebouche, Bertrand
    Metz, Gila
    Rogers, Tim
    Shafran, Stephen
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (47) : E1448 - E1458
  • [39] Pre-exposure prophylaxis, a new tool for prevention against HIV
    Pialoux, G.
    Chas, J.
    Bonnard, P.
    JOURNAL DES ANTI-INFECTIEUX, 2012, 14 (04) : 175 - 179
  • [40] A pilot program of HIV pre-exposure prophylaxis in Thai youth
    Rungmaitree, Supattra
    Werarak, Peerawong
    Pumpradit, Wadchara
    Phongsamart, Wanatpreeya
    Lapphra, Keswadee
    Wittawatmongkol, Orasri
    Durier, Yuitiang
    Maleesatharn, Alan
    Kuttiparambil, Beena
    Cressey, Tim R.
    Hoffman, Risa M.
    Chokephaibulkit, Kulkanya
    PLOS ONE, 2024, 19 (02):